Percutaneous transluminal dilatation and recanalization in the treatment of peripheral vascular disease.

Authors:
  • RCR F Colapinto
    R F Colapinto
  • EHE P Harries-Jones
    E P Harries-Jones
  • KJK W Johnston
    K W Johnston

Abstract
Successful transluminal angioplasties (94) were followed up for as long as 15 mo., during which time 15 failures occurred. Life-table analysis of this series gave a cumulative patency rate of 64%. The patency rate of 70% for iliac lesions compared to 50% for the femoral-popliteal group suggests that the former are likely to have a better long-term prognosis. In selected cases transluminal angioplasty is a viable alternative to surgery that should be available to patient and physician.

This publication has 2 references indexed in Scilit: